Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR

被引:278
作者
Hajduk, PJ [1 ]
Sheppard, G [1 ]
Nettesheim, DG [1 ]
Olejniczak, ET [1 ]
Shuker, SB [1 ]
Meadows, RP [1 ]
Steinman, DH [1 ]
Carrera, GM [1 ]
Marcotte, PA [1 ]
Severin, J [1 ]
Walter, K [1 ]
Smith, H [1 ]
Gubbins, E [1 ]
Simmer, R [1 ]
Holzman, TF [1 ]
Morgan, DW [1 ]
Davidsen, SK [1 ]
Summers, JB [1 ]
Fesik, SW [1 ]
机构
[1] ABBOTT LABS,DIV PHARMACEUT DISCOVERY,ABBOTT PK,IL 60064
关键词
D O I
10.1021/ja9702778
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With the use of an NMR-based method, potent (IC50 < 25 nM) nonpeptide inhibitors of the matrix metalloproteinase stromelysin (MMP-3) were discovered. The method, called SAR by NMR (for structure-activity relationships by nuclear magnetic resonance), involves the identification, optimization, and linking of compounds that bind to proximal sites on a protein. Using this technique, two ligands that bind weakly to stromelysin (acetohydroxamic acid, K-D = 17 mM; 3-(cyanomethyl)-4'-hydroxybiphenyl, K-D = 0.02 mM) were identified. On the basis of NMR-derived structural information, the two fragments were connected to produce a 15 nM inhibitor of this enzyme. This compound was rapidly discovered (less than 6 months) and required only a minimal amount of chemical synthesis. These studies indicate that the SAR by NMR method can be effectively applied to enzymes to yield potent lead inhibitors-an important part of the drug discovery process.
引用
收藏
页码:5818 / 5827
页数:10
相关论文
共 44 条
  • [1] SYNTHESIS OF ORGANOTRIALKYLSTANNANES - THE REACTION BETWEEN ORGANIC HALIDES AND HEXAALKYLDISTANNANES IN THE PRESENCE OF PALLADIUM COMPLEXES
    AZIZIAN, H
    EABORN, C
    PIDCOCK, A
    [J]. JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1981, 215 (01) : 49 - 58
  • [2] BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573
  • [3] METHODOLOGICAL ADVANCES IN PROTEIN NMR
    BAX, A
    GRZESIEK, S
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 1993, 26 (04) : 131 - 138
  • [4] OPTIMIZED RECORDING OF HETERONUCLEAR MULTIDIMENSIONAL NMR-SPECTRA USING PULSED FIELD GRADIENTS
    BAX, A
    POCHAPSKY, SS
    [J]. JOURNAL OF MAGNETIC RESONANCE, 1992, 99 (03): : 638 - 643
  • [5] STROMELYSIN-1 - 3-DIMENSIONAL STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN AND OF THE C-TRUNCATED PROENZYME
    BECKER, JW
    MARCY, AI
    ROKOSZ, LL
    AXEL, MG
    BURBAUM, JJ
    FITZGERALD, PMD
    CAMERON, PM
    ESSER, CK
    HAGMANN, WK
    HERMES, JD
    SPRINGER, JP
    [J]. PROTEIN SCIENCE, 1995, 4 (10) : 1966 - 1976
  • [6] Recent advances in matrix metalloproteinase inhibitor research
    Beckett, RP
    Davidson, AH
    Drummond, AH
    Huxley, P
    Whittaker, M
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (01) : 16 - 26
  • [7] THE X-RAY CRYSTAL-STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NEUTROPHIL COLLAGENASE INHIBITED BY A SUBSTRATE-ANALOG REVEALS THE ESSENTIALS FOR CATALYSIS AND SPECIFICITY
    BODE, W
    REINEMER, P
    HUBER, R
    KLEINE, T
    SCHNIERER, S
    TSCHESCHE, H
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1263 - 1269
  • [8] INHIBITION OF COLLAGENASE BY ARANCIAMYCIN AND ARANCIAMYCIN DERIVATIVES
    BOLS, M
    BINDERUP, L
    HANSEN, J
    RASMUSSEN, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) : 2768 - 2771
  • [9] STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
    BORKAKOTI, N
    WINKLER, FK
    WILLIAMS, DH
    DARCY, A
    BROADHURST, MJ
    BROWN, PA
    JOHNSON, WH
    MURRAY, EJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (02): : 106 - 110
  • [10] Brunger AT, 1992, X PLOR 3 1 MANUAL